Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page’s Locations section was updated to add numerous locations across the US, Australia, Canada, Europe and Asia, and several previously listed sites were removed.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Revision: v3.3.2.SummaryDifference0.0%

- Check40 days agoChange DetectedThe funding-lapse operating-status notice on the page was removed, eliminating the informational banner about potential processing delays. This change does not affect the study details or accessibility of the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check47 days agoChange DetectedTaiwan site entry updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'. This is a naming correction in the locations list to reflect the correct city name.SummaryDifference0.0%

- Check54 days agoChange DetectedThe study locations list has been expanded across many countries, and the last update date on the record has been refreshed to reflect updated information.SummaryDifference0.2%

- Check83 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.